Liposomes to Augment Dialysis in Preclinical Models; A Structured Review
In recent years, a number of groups have been investigating the use of “empty” liposomes with no drug loaded as scavengers both for exogenous intoxicants and endogenous toxic molecules. Preclinical trials have demonstrated that repurposing liposomes to sequester such compounds may prove clinically u...
Main Authors: | Kevin Hart, Martyn Harvey, Mingtan Tang, Zimei Wu, Grant Cave |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/3/395 |
Similar Items
-
Early initiation of MARS® dialysis in Amanita phalloides-induced acute liver injury prevents liver transplantation
by: Mike Hendrik Pillukat, et al.
Published: (2016-09-01) -
A Rare Outcome Induced by Metformin Intoxication: Severe Lactic Acidosis and Hepatotoxicity
by: Elyigit Faruk, et al.
Published: (2016-06-01) -
Outcomes after toxic alcohol poisoning: a systematic review protocol
by: Carol Wang, et al.
Published: (2018-12-01) -
Factors influencing dialysis withdrawal: a scoping review
by: Hammad Ali Qazi, et al.
Published: (2018-04-01) -
Liposomal Irinotecan for Treatment of Colorectal Cancer in a Preclinical Model
by: Jiao-Ren Huang, et al.
Published: (2019-02-01)